Biodesix Inc (BDSX) concluded trading on Thursday at a closing price of $0.22, with 17.1 million shares of worth about $3.76 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -84.40% during that period and on May 15, 2025 the price remained unchanged. Currently the company’s common shares owned by public are about 146.44M shares, out of which, 74.20M shares are available for trading.
Stock saw a price change of -36.75% in past 5 days and over the past one month there was a price change of -61.54%. Year-to-date (YTD), BDSX shares are showing a performance of -85.62% which decreased to -85.53% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.19 but also hit the highest price of $2.04 during that period. The average intraday trading volume for Biodesix Inc shares is 596.31K. The stock is currently trading -51.41% below its 20-day simple moving average (SMA20), while that difference is down -63.29% for SMA50 and it goes to -82.00% lower than SMA200.
Biodesix Inc (NASDAQ: BDSX) currently have 146.44M outstanding shares and institutions hold larger chunk of about 38.09% of that.
The stock has a current market capitalization of $32.24M and its 3Y-monthly beta is at 0.94. It has posted earnings per share of -$0.29 in the same period. It has Quick Ratio of 2.14 while making debt-to-equity ratio of 5.63. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for BDSX, volatility over the week remained 27.67% while standing at 17.19% over the month.
Stock’s fiscal year EPS is expected to rise by 26.92% while it is estimated to increase by 38.65% in next year. EPS is likely to shrink at an annualized rate of 33.97% for next 5-years, compared to annual growth of 69.26% made by the stock over the past 5-years.
On July 26, 2024, Craig Hallum Initiated their recommendations, while on May 13, 2024, TD Cowen Initiated their ratings for the stock with a price target of $2.80. Stock get a Buy rating from Lake Street on May 03, 2024.
